3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
2
Phase NA
1
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
9
Genitourinary
8
Head & Neck
7
Thoracic
4
Lymphoid
4
Other hematologic neoplasm
3
Gynecologic
3
Breast
3
Plasma cell
2
Dermatologic
2
CNS
2
Other solid neoplasm
1
Other neoplasm
1
Other
1
Endocrine
1
Conditions
Multiple Myeloma
2
Recurrence
1
Infections
1
Interventions
Dexamethasone
373
Lenalidomide
206
Bortezomib
200
Cyclophosphamide
178
Melphalan
135
Calcium Dobesilate
120
daratumumab
107
pomalidomide
74
carfilzomib
74
fludarabine phosphate
71
Peripheral Blood Stem Cell Transplantation
66
Thalidomide
57
Filgrastim
57
Mycophenolic Acid
56
Busulfan
55
Tacrolimus
48
Granulocyte Colony-Stimulating Factor
47
ixazomib
45
fludarabine
45
Whole-Body Irradiation
44
dexamethasone acetate
36
Cyclosporine
35
isatuximab
34
Etoposide
34
Antilymphocyte Serum
32
dexamethasone 21-phosphate
30
elotuzumab
28
auricularum
27
Prednisone
27
plerixafor
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Observation
×
Plasma cell
×
Clear all
NCT02572492
2018-08-17
CARFI
Aalborg University Hospital
Phase 2
Unknown
200 enrolled
NCT02624440
2015-12-08
SUTRICA
Aalborg University Hospital
Phase 2
Unknown
300 enrolled